Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameFangzhou Jianke
Stock Code06086
Company Full NameFangzhou Inc.
Industry醫療保健
Principal Activities公司是是中國最大的在線慢病管理平臺,為不斷增長的慢病患者提供覆蓋整個疾病周期的定制醫療護理及精準醫療,目標為將覆蓋整個疾病周期的服務推廣至更廣泛的疾病領域。
Listing Date2024-07-09
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省廣州市黃埔區蘿崗科學城科學大道99號科匯金谷S棟四街一至二樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://investors.jianke.com/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 8.18 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 4,090
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering Shares23,800,000 shares
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)Citigroup Global Markets Asia Limited CE AAA137
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 194,684,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 4,090
2 lots 1,000 HK$ 8,180
3 lots 1,500 HK$ 12,270
4 lots 2,000 HK$ 16,360
5 lots 2,500 HK$ 20,450
6 lots 3,000 HK$ 24,540
7 lots 3,500 HK$ 28,630
8 lots 4,000 HK$ 32,720
9 lots 4,500 HK$ 36,810
10 lots 5,000 HK$ 40,900
12 lots 6,000 HK$ 49,080
14 lots 7,000 HK$ 57,260
16 lots 8,000 HK$ 65,440
18 lots 9,000 HK$ 73,620
20 lots 10,000 HK$ 81,800
30 lots 15,000 HK$ 122,700
40 lots 20,000 HK$ 163,600
50 lots 25,000 HK$ 204,500
60 lots 30,000 HK$ 245,400
70 lots 35,000 HK$ 286,300
80 lots 40,000 HK$ 327,200
90 lots 45,000 HK$ 368,100
100 lots 50,000 HK$ 409,000
120 lots 60,000 HK$ 490,800
140 lots 70,000 HK$ 572,600
160 lots 80,000 HK$ 654,400
180 lots 90,000 HK$ 736,200
200 lots 100,000 HK$ 818,000
400 lots 200,000 HK$ 1,636,000
600 lots 300,000 HK$ 2,454,000
800 lots 400,000 HK$ 3,272,000
1,000 lots 500,000 HK$ 4,090,000
1,200 lots 600,000 HK$ 4,908,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,400 lots 700,000 HK$ 5,726,000
2,380 lots 1,190,000 HK$ 9,734,200

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 1.74B
Est. Threshold HK$ 9.39B
Analysis Result HK market cap below threshold, need +439%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceRMB 146.32 million
Listing ExpensesTo be extracted
Listing Expenses / Funds Raised~66.8%
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 4.53
First Day OpenHK$ 4.68
First Day Change-44.62%
First Day Volume9892000.0
First Day Turnover46415800.0
Use of Proceeds
1、約67.4%或42.51百萬港元將于未來三至五年用于拓展業務; 2、約16.0%或10.09百萬港元將于未來五年用于研發活動; 3、約11.6%或7.32百萬港元將用于公司對在線慢性疾病管理行業價值鏈中的其他利益相關者的潛在投資和收購或戰略聯盟; 4、約5.0%或3.15百萬港元將用作公司的運營資金和一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
Citigroup Global Markets Asia Limited CE AAA137 农银国际融资有限公司 CE AWL249
Overall Coordinators (5)
Citigroup Global Markets Asia Limited CE AAA137 农银国际证券有限公司 CE ACX411 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 中国银河国际证券(香港)有限公司 CE AXM459
Joint Bookrunners (19)
Citigroup Global Markets Asia Limited CE AAA137 农银国际证券有限公司 CE ACX411 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 中国银河国际证券(香港)有限公司 CE AXM459 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 CITRUS SECURITIES LIMITED CE BPX754 招银国际融资有限公司 CE AVM940 Fosun International Securities Limited CE AAF432 富途证券国际(香港)有限公司 CE AZT137 广发证券(香港)经纪有限公司 CE AOB364 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 Long Bridge HK Limited CE BPX066 SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927 老虎证券(香港)环球有限公司 CE BMU940 VICTORY SECURITIES COMPANY LIMITED CE ABN091 YUE XIU SECURITIES COMPANY LIMITED CE ABQ722 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Joint Lead Managers (19)
Citigroup Global Markets Asia Limited CE AAA137 农银国际证券有限公司 CE ACX411 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 中国银河国际证券(香港)有限公司 CE AXM459 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 CITRUS SECURITIES LIMITED CE BPX754 招银国际融资有限公司 CE AVM940 Fosun International Securities Limited CE AAF432 富途证券国际(香港)有限公司 CE AZT137 广发证券(香港)经纪有限公司 CE AOB364 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 Long Bridge HK Limited CE BPX066 SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927 老虎证券(香港)环球有限公司 CE BMU940 VICTORY SECURITIES COMPANY LIMITED CE ABN091 YUE XIU SECURITIES COMPANY LIMITED CE ABQ722 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Stabilizing Manager (1)
Citigroup Global Markets Asia Limited CE AAA137

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
ChairmanDavid McKee HAND—
Company Secretary鄒宇鳴;伍秀薇—
No director data available.

Major Shareholders

Major Shareholders & HoldingsCrescent Point投資實體(32.64%);Fangrong Management Limited(19.81%);Celaeno Group Limited(13.89%)
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.

Market Sentiment

The IPO was 16.63 times oversubscribed, indicating moderate market enthusiasm. The overall hit rate of 63.81% suggests relatively broad allocations, typical for a less aggressively sought offering. Final pricing at HK$8.18 reflected stable demand without a clear signal of severe underpricing or overpricing. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

The data reveals a classic inefficiency: the last A-tier applicant (HK$600,000) and the first B-tier applicant (HK$700,000) both received only 1 expected lot, making the additional HK$100,000 in the B-head subscription yield no marginal benefit. This dulls the incentive to cross into B-head territory and may reflect a poorly calibrated threshold. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic details such as mainland participation, gender, or regional distribution are not available in the provided data, precluding any analysis of applicant population trends. Without this information, no meaningful demographic conclusions can be drawn. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Fangzhou Jianke (06086) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect